# STLNW (Starling Oncology, Inc.) - SEC EDGAR Financial Statements

> Starling Oncology, Inc. reported $620.4M in revenue and a net loss of $35.54M for the trailing twelve months ended September 30, 2026 (up 24.3% year over year), with a -3.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/STLNW
- Markdown: https://convexityos.com/fundamentals/STLNW.md
- SEC CIK: 0001799191
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:35 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001799191&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $620.4M | +24.3% YoY |
| Operating Income | TTM | -$21.02M | -3.4% margin |
| Net Income | TTM | -$35.54M | -5.7% net margin |
| Diluted EPS | TTM | -$0.34 | Split-adjusted |
| Free Cash Flow | TTM | $18.83M | 3.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $97.77M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $502.7M | $393.4M | $324.2M | $252.5M | $203.0M | $187.5M |
| Selling, General & Admin | $105.6M | $107.8M | $113.9M | $119.7M | $83.36M | $41.90M |
| **Operating Income** | -$36.08M | -$60.12M | -$77.02M | -$81.95M | -$45.86M | -$8.20M |
| **EBITDA** | -$29.14M | -$53.83M | -$71.14M | -$77.54M | -$42.52M | -$5.02M |
| Interest Income | -- | -- | -- | -- | -- | $254K |
| Interest Expense | $11.28M | $7.50M | $6.78M | -- | $320K | $347K |
| Income Before Tax | -$60.74M | -$64.66M | -$83.10M | -$91K | -$11.60M | -$14.81M |
| Income Tax Expense | -$131K | $0 | -$36K | -$243K | -$671K | -$493K |
| **Net Income** | -$60.61M | -$64.66M | -$83.07M | $152K | -$10.93M | -$14.32M |
| Basic EPS | -$0.54 | -$0.71 | -$0.92 | $0.00 | -$0.16 | -$0.24 |
| **Diluted EPS** | -$0.54 | -$0.71 | -$0.92 | -$0.21 | -$0.16 | -$0.24 |
| Basic Shares Outstanding | 92.4M | 75.0M | 73.7M | 72.8M | 66.2M | 59.1M |
| Diluted Shares Outstanding | 92.4M | 75.0M | 73.7M | 80.6M | 66.2M | 59.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $169.8M | $161.3M | $147.4M | $142.0M | $136.6M | $119.8M | $104.4M | $100.3M |
| Selling, General & Admin | $32.13M | $29.94M | $28.21M | $28.04M | $25.25M | $26.91M | $25.38M | $24.86M |
| **Operating Income** | -$2.98M | -$4.62M | -$6.51M | -$6.91M | -$8.05M | -$11.21M | -$9.91M | -$11.93M |
| **EBITDA** | -$1.46M | -$2.78M | -$4.90M | -$5.28M | -$6.33M | -$9.41M | -$8.13M | -$10.22M |
| Interest Expense | $1.81M | $1.86M | $1.93M | $4.80M | $1.92M | $1.87M | $5.57M | $1.17M |
| Income Before Tax | -$15.75M | -$9.79M | -$2.49M | -$7.51M | -$16.50M | -$17.14M | -$19.59M | -$13.18M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$131K | $0 | $0 |
| **Net Income** | -$15.75M | -$9.79M | -$2.49M | -$7.51M | -$16.50M | -$17.01M | -$19.59M | -$13.18M |
| Basic EPS | -$0.13 | -$0.08 | -$0.02 | -- | -$0.14 | -$0.15 | -$0.21 | -- |
| **Diluted EPS** | -$0.13 | -$0.08 | -$0.02 | -- | -$0.14 | -$0.15 | -$0.21 | -- |
| Basic Shares Outstanding | 104.7M | 103.0M | 101.8M | -- | 97.5M | 93.2M | 77.1M | -- |
| Diluted Shares Outstanding | 104.7M | 103.0M | 101.8M | -- | 97.5M | 93.2M | 77.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | -- | -- | $900K | $25K |
| Short-Term Investments | -- | $0 | $49.37M | $59.80M | $0 | -- | -- |
| **Cash & Short-Term Investments** | -- | -- | -- | -- | -- | $900K | $25K |
| Accounts Receivable, Net | $59.00M | $48.34M | $42.36M | $39.82M | $20.01M | $17.15M | -- |
| Inventory | $16.88M | $10.04M | $13.68M | $9.26M | $6.44M | $4.35M | -- |
| **Total Current Assets** | $112.7M | $112.4M | $143.5M | $130.4M | $154.1M | $29.72M | $25K |
| Property, Plant & Equipment, Net | $10.68M | $11.89M | $10.88M | $8.55M | $4.19M | $2.10M | -- |
| Goodwill | $7.23M | $7.23M | $7.23M | $21.42M | $26.63M | $14.23M | -- |
| Intangible Assets | $11.02M | $14.81M | $17.90M | $17.96M | $18.25M | $19.52M | -- |
| Long-Term Investments | -- | -- | $0 | $58.35M | $0 | -- | -- |
| Other Non-Current Assets | $606K | $589K | $561K | $477K | $320K | $122K | -- |
| **Total Non-Current Assets** | $51.91M | $60.30M | $65.75M | $131.2M | $49.38M | $35.97M | $25K |
| **Total Assets** | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M | $65.69M | $50K |
| Accounts Payable | $43.17M | $24.32M | $14.43M | $9.37M | $15.56M | $12.64M | -- |
| Short-Term Debt | -- | -- | -- | $0 | $183K | $5.37M | -- |
| Deferred Revenue (Current) | $2.28M | $2.35M | $545K | $1.14M | $262K | -- | -- |
| Other Current Liabilities | $20.64M | $21.09M | $14.00M | $14.60M | $13.92M | $9.45M | -- |
| **Total Current Liabilities** | $70.96M | $52.22M | $34.79M | $29.72M | $29.80M | $28.61M | $27K |
| Long-Term Debt | $77.40M | $93.13M | $86.83M | $80.62M | $0 | $6.56M | -- |
| Other Non-Current Liabilities | $28K | $125K | $365K | $868K | $6.90M | $807K | -- |
| **Total Non-Current Liabilities** | $109.4M | $116.9M | $117.4M | $108.8M | $69.48M | $8.98M | $0 |
| **Total Liabilities** | $180.4M | $169.1M | $152.2M | $138.5M | $99.28M | $37.59M | $27K |
| **Total Debt (incl. Leases)** | $103.8M | $123.3M | $119.8M | $108.4M | $183K | $11.93M | -- |
| Common Stock | $10K | $8.0K | $8.0K | $7.0K | $7.0K | $6.0K | -- |
| Retained Earnings | -$271.4M | -$210.8M | -$146.2M | -$63.08M | -$63.23M | -$52.31M | -$2.3K |
| **Total Stockholders' Equity** | -$15.72M | $3.59M | $57.02M | $123.2M | $104.2M | $28.10M | $42.22M |
| Total Equity | -$15.72M | $3.59M | $57.02M | $123.2M | $104.2M | $28.10M | $42.22M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Accounts Receivable, Net | $60.68M | $66.35M | $58.13M | $59.00M | $59.64M | $55.66M | $49.32M | $48.34M |
| Inventory | $36.63M | $20.01M | $24.29M | $16.88M | $18.88M | $15.79M | $12.31M | $10.04M |
| **Total Current Assets** | $137.7M | $129.0M | $116.9M | $112.7M | $110.1M | $104.8M | $106.8M | $112.4M |
| Property, Plant & Equipment, Net | $10.59M | $10.58M | $10.70M | $10.68M | $10.71M | $10.85M | $11.12M | $11.89M |
| Goodwill | $7.23M | $7.23M | $7.23M | $7.23M | $7.23M | $7.23M | $7.23M | $7.23M |
| Intangible Assets | $8.87M | $9.59M | $10.30M | $11.02M | $11.73M | $12.45M | $14.04M | $14.81M |
| Other Non-Current Assets | $1.42M | $657K | $620K | $606K | $586K | $586K | $591K | $589K |
| **Total Non-Current Assets** | $50.08M | $49.24M | $51.37M | $51.91M | $53.53M | $55.01M | $57.18M | $60.30M |
| **Total Assets** | $187.8M | $178.2M | $168.2M | $164.7M | $163.6M | $159.8M | $164.0M | $172.7M |
| Accounts Payable | $82.09M | $60.28M | $47.65M | $43.17M | $35.63M | $34.93M | $29.29M | $24.32M |
| Deferred Revenue (Current) | -- | -- | -- | $2.28M | $4.90M | $5.20M | $4.08M | $2.35M |
| Other Current Liabilities | $29.34M | $27.43M | $24.30M | $20.64M | $22.79M | $22.89M | $23.43M | $21.09M |
| **Total Current Liabilities** | $123.7M | $94.94M | $79.35M | $70.96M | $65.58M | $64.78M | $59.54M | $52.22M |
| Long-Term Debt | $72.52M | $79.87M | $78.61M | $77.40M | $76.19M | $75.02M | $73.89M | $93.13M |
| Other Non-Current Liabilities | $25K | $30K | $19K | $28K | $3.0K | $10K | $117K | $125K |
| **Total Non-Current Liabilities** | $101.4M | $108.2M | $105.2M | $109.4M | $110.3M | $104.0M | $99.39M | $116.9M |
| **Total Liabilities** | $225.1M | $203.1M | $184.5M | $180.4M | $175.9M | $168.8M | $158.9M | $169.1M |
| **Total Debt (incl. Leases)** | $97.77M | $104.5M | $104.9M | $103.8M | $103.6M | $103.2M | $102.4M | $123.3M |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $9.0K | $9.0K | $8.0K |
| Retained Earnings | -$299.4M | -$283.7M | -$273.9M | -$271.4M | -$263.9M | -$247.4M | -$230.4M | -$210.8M |
| **Total Stockholders' Equity** | -$37.35M | -$24.91M | -$16.29M | -$15.72M | -$12.27M | -$8.98M | $5.07M | $3.59M |
| Total Equity | -$37.35M | -$24.91M | -$16.29M | -$15.72M | -$12.27M | -$8.98M | $5.07M | $3.59M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$60.61M | -$64.66M | -$83.07M | $152K | -$10.93M | -$441K |
| Depreciation & Amortization | $6.94M | $6.29M | $5.87M | $4.41M | $3.34M | $3.18M |
| Stock-Based Compensation | $4.55M | $11.15M | $17.81M | $27.68M | $24.54M | $151K |
| Change in Receivables | -$12.31M | -$5.97M | -$4.56M | -$20.29M | -$2.19M | -$6.76M |
| Change in Inventory | -$6.84M | $3.64M | -$4.38M | -$1.73M | -$1.84M | -$465K |
| Change in Payables | $19.64M | $9.21M | $5.06M | -$6.19M | $2.92M | $3.76M |
| **Operating Cash Flow** | -$24.59M | -$26.54M | -$36.31M | -$61.76M | -$32.68M | $508K |
| Capital Expenditure | -$3.20M | -$3.79M | -$4.57M | -$5.53M | -$2.85M | -$1.19M |
| **Free Cash Flow** | -$27.79M | -$30.33M | -$40.88M | -$67.28M | -$35.53M | -$686K |
| Acquisitions, Net | -- | $0 | -$4.46M | -$8.58M | -$9.11M | -$150K |
| Purchases of Investments | -- | $0 | -$9.60M | -$117.5M | $0 | -- |
| **Investing Cash Flow** | -$3.07M | $46.21M | $62.64M | -$131.6M | -$12.15M | -$8.84M |
| Common Stock Issued | $13.84M | $0 | $126K | -- | -- | -- |
| Share Repurchases | -- | $0 | -$1.02M | -$9.00M | $0 | -- |
| **Financing Cash Flow** | $11.56M | -$3.49M | -$6.85M | $92.21M | $154.0M | $11.89M |
| **Net Change in Cash** | -$16.10M | $16.18M | $19.48M | -$101.2M | $109.2M | $3.55M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.75M | -$9.79M | -$2.49M | -$7.51M | -$16.50M | -$17.01M | -$19.59M | -$13.18M |
| Depreciation & Amortization | $1.52M | $1.84M | $1.62M | $1.63M | $1.72M | $1.80M | $1.78M | $1.71M |
| Stock-Based Compensation | $1.35M | $1.07M | $1.69M | $1.32M | $1.02M | $752K | $1.46M | $1.29M |
| Change in Receivables | $5.47M | -$8.21M | $864K | $641K | -$3.98M | -$7.98M | -$985K | $6.17M |
| Change in Inventory | -$16.62M | $4.28M | -$7.42M | $2.01M | -$3.10M | -$3.48M | -$2.27M | $67K |
| Change in Payables | $22.14M | $12.50M | $4.61M | $7.71M | $439K | $6.43M | $5.06M | $739K |
| **Operating Cash Flow** | $10.14M | $11.94M | -$2.21M | $3.23M | -$12.63M | -$10.20M | -$4.99M | $4.00M |
| Capital Expenditure | -$1.26M | -$908K | -$1.04M | -$1.06M | -$604K | -$1.21M | -$328K | -$1.75M |
| **Free Cash Flow** | $8.88M | $11.03M | -$3.26M | $2.17M | -$13.23M | -$11.41M | -$5.32M | $2.25M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Investing Cash Flow** | -$1.26M | -$908K | -$1.04M | -$1.06M | -$604K | -$1.21M | -$202K | -$1.75M |
| Common Stock Issued | -- | -- | -- | $3.89M | $7.61M | $2.20M | $137K | $0 |
| **Financing Cash Flow** | -$13.08M | -$218K | -$28K | $3.73M | $10.60M | $1.96M | -$4.74M | -$164K |
| **Net Change in Cash** | -$4.20M | $10.81M | -$3.29M | $5.91M | -$2.63M | -$9.45M | -$9.93M | $2.27M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -7.2% | -15.3% | -23.8% | -32.5% | -22.6% | -4.4% |
| **Net Profit Margin** | -12.1% | -16.4% | -25.6% | 0.1% | -5.4% | -7.6% |
| Return on Equity (ROE) | -- | -1801.7% | -145.7% | 0.1% | -10.5% | -51.0% |
| Return on Assets (ROA) | -36.8% | -37.4% | -39.7% | 0.1% | -5.4% | -21.8% |
| Current Ratio | 1.59x | 2.15x | 4.12x | 4.39x | 5.17x | 1.04x |
| Quick Ratio | 1.35x | 1.96x | 3.73x | 4.08x | 4.95x | 0.89x |
| Debt to Equity | -- | 34.34x | 2.10x | 0.88x | 0.00x | 0.42x |
| **Revenue Growth (YoY)** | +27.8% | +21.3% | +28.4% | +24.4% | +8.3% | -- |
| **Net Income Growth (YoY)** | -- | -- | -54750.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -6533.1% | -- |
| 5Y Revenue / Share Growth | +71.6% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -3.4% | -4.4% | -6.0% | -7.2% | -8.9% | -11.1% | -12.9% | -15.3% |
| **Net Profit Margin** | -5.7% | -6.2% | -8.0% | -12.1% | -14.4% | -15.5% | -16.0% | -16.4% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -1269.7% | -1801.7% |
| Return on Assets (ROA) | -18.9% | -20.4% | -25.9% | -36.8% | -40.5% | -41.2% | -39.2% | -37.4% |
| Current Ratio | 1.11x | 1.36x | 1.47x | 1.59x | 1.68x | 1.62x | 1.79x | 2.15x |
| Quick Ratio | 0.82x | 1.15x | 1.17x | 1.35x | 1.39x | 1.37x | 1.59x | 1.96x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 20.20x | 34.34x |
| **Revenue Growth (YoY)** | +24.3% | +34.6% | +41.2% | +41.6% | +36.7% | +21.5% | +10.3% | +16.9% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -19.2% | -1642.1% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -3.2% | -1183.9% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
